MAPT and Parkinson disease: Tau positron emission tomography (Tau-PET), employing specific tracers such as [18F]AV-1451 and [18F]MK-6240, visualizes tau protein deposits, illustrating the spatial characteristics of tau pathology in PD-MCI and their relationship to cognitive decline.